Erasca to Present at Upcoming Conferences in February

Core Viewpoint - Erasca, Inc. is actively participating in investor conferences in February 2026 to enhance visibility and engagement with potential investors [1][2]. Company Overview - Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers [3]. - The company aims to "erase cancer" by creating novel therapies and combination regimens that comprehensively target the RAS/MAPK pathway [3]. - Erasca's team includes leading pioneers in precision oncology and is supported by a scientific advisory board of experts in the RAS/MAPK pathway, positioning the company to achieve its mission [3]. Upcoming Events - Erasca will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 11-12, 2026, with a fireside chat scheduled for February 12 at 1:00 pm Eastern Time [2]. - The company will also be part of the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026, with a fireside chat on February 26 at 11:20 am Eastern Time [2]. - Live audio webcasts of these events will be available on Erasca's website, with archived replays accessible for 30 days post-event [2].